Company: SHPH
Filing Date: 2025-03-12
Form Type: 8-K
Source: 0001493152-25-009922
Chunk: 2

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-12
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item
9.01. Financial Statements and Exhibits.

(d)
Exhibits.

  Exhibit      Description                                                                                                         
                                                                                                                                   
      No.                                                                                                                          
     10.1      Employment Agreement, dated March 11, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and Christopher Cooper.  
     99.1      Press Release dated March 12, 2025                                                                                  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive                                                                                              

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE PHARMACEUTICALS HOLDINGS, INC.                               
  By:                                         /s/ Anatoly              
  Name:                                       Anatoly Dritschilo       
  Title:                                      Chief Executive Officer